MedPath

To STUDY THE EFFECT OF PANCHAKARMA THERAPY NAMED BASTI OF COMBINATION CHATUPRASRUTIK BASTI IN SHUKRA-ALPTA WITH SPECIAL REFERENCE TO OLIGOSPERMIA

Phase 2
Completed
Conditions
Health Condition 1: N461- Oligospermia
Registration Number
CTRI/2021/02/031162
Lead Sponsor
Dr Sagar Fulaji Magar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Diagnosed cases of Oligospermia on the basis of semen analysis,

-Patient who will give written consent

Exclusion Criteria

Patients suffering from systemic diseases like cirrhosis of liver, CRF, etc

-Patients with structuraldeformity like Epispadias, Hypospadias, Cryptorchidism, Hydrocele, Vericocele etc.

-Azoospermia, Aspermia, Necrozoospermia and Teratozoospermia.

-Seminoma

-Diabetes

-Drug abuse patient

-Patients receiving antihypertensive treatment

-Individuals having previous history of chemotherapy or exposure to radiation.

-Patients having genetic and congenital disorders.

-Unmarried patient

- Patient having addiction of Tobacco, smoking, Alcohol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Chatuprasrutik Basti will be effective in Oligospermia. <br/ ><br>2) Sperm count and sperm mobility will be increases after treatment.Timepoint: 12 wks
Secondary Outcome Measures
NameTimeMethod
Male Infertility problem will overcomeTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath